Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00520312 · ClinicalTrials.gov registry record

Magnetic Resonance Imaging to Identify Characteristics of Plaque Build-Up in People With Peripheral Arterial Disease

A clinical trial of Peripheral Vascular Diseases, sponsored by Northwestern University.

Completed
Registry status
519
Enrollment target
1
Study location

NCT00520312 is a study of Peripheral Vascular Diseases that has completed, run by Northwestern University. The registered enrollment target is 519 participants, above the 469-participant average among 19 other Peripheral Vascular Diseases trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00520312, a study of Peripheral Vascular Diseases, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
519 participants
Enrollment target
1
Study location

Study Summary

Peripheral arterial disease (PAD) is a disease in which fatty build-up, or "plaque," accumulates in the peripheral arteries. People with PAD often experience leg pain while walking due to reduced blood flow to the legs. This study will use magnetic resonance imaging (MRI) techniques to examine how specific features of plaque build-up in the leg arteries affect walking ability, leg strength, and balance in people with PAD.

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 519 participants
Start Date 2007-10
Est. Completion 2012-01

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT00520312

The ClinicalTrials.gov registry entry for NCT00520312 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 519 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 469-participant average among 19 other Peripheral Vascular Diseases trials with a reported enrollment target (11% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Vascular Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT00520312 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00520312 about?

NCT00520312 is a clinical study titled "Magnetic Resonance Imaging to Identify Characteristics of Plaque Build-Up in People With Peripheral Arterial Disease". Peripheral arterial disease (PAD) is a disease in which fatty build-up, or "plaque," accumulates in the peripheral arteries. People with PAD often experience leg pain while walking due to reduced blood flow to the legs. This study will use magnetic resonance imaging (MRI) techniques to examine how s...

What is the current status of trial NCT00520312?

This trial is currently completed. The enrollment target is 519 participants. The study started on 2007-10. Estimated completion is 2012-01.

What conditions does trial NCT00520312 study?

This clinical trial studies the following conditions: Peripheral Vascular Diseases.

Who is sponsoring clinical trial NCT00520312?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00520312 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Vascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.